iSOFT Launches Web-Based E-Prescribing Solution for the NHS

iSOFT Group LimitediSOFT Group Limited (ASX:ISF) has launched a new e-prescribing and medication administration (ePMA) solution in the UK and is close to finalising deals with a number of NHS trusts to become early adopters.

The solution is already used at ten hospitals in Australia and across six district health boards in New Zealand for safer and more efficient medicines management. Users report sharp falls in incidents due to drugs being wrongly prescribed or doses being missed. And incidents due to illegible scripts are a thing of the past.

Working with First DataBank, a leading provider of drug databases and active clinical decision support, iSOFT has adapted the solution for the UK market. It offers a drug formulary and decision support rules engine to stop drugs being wrongly prescribed and so shorten hospital stays. It will also streamline processes such as discharge, reduce re-admission rates, and cut costs.

"We have a very strong, if not unique, proposition in combining the scale and capability of iSOFT to deliver a best of breed ePMA solution," said Adrian Stevens, Managing Director of iSOFT's UK and Ireland business.

"This is also very timely following the recent publication of the UK government's white paper, Equity and Excellence: Liberating the NHS, which highlights the importance of improving healthcare outcomes and patient safety.

"Last year, the National Patient Safety Agency reported that more than 200 patients every month need further treatment or die because of medication mistakes. Our ePMA solution can help to drastically reduce this statistic."

The solution is specifically designed to allow NHS trusts that have already invested in elements of an electronic patient record to introduce a fully integrated and comprehensive ePMA solution.

Mark Treleaven, Sales and Marketing Director, First DataBank said: "It is clear that iSOFT's new solution has been designed to meet the specialist requirements of prescribing and administering medicines. As such, we are very excited to see our product associated with an initiative that will make full use of the Multilex DDF sophistication."

The first early adopter sites are expected to go-live in 2011. The software will be exhibited at various events throughout the year including E-Health Insider Live in November.

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organisations.

Today, more than 13,000 provider organisations in over 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,700 specialists in 19 countries worldwide, including more than 2,700 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

www.isofthealth.com

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

Personalized Breast Cancer Prevention No…

A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast...

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

An App to Detect Heart Attacks and Strok…

A potentially lifesaving new smartphone app can help people determine if they are suffering heart attacks or strokes and should seek medical attention, a clinical study suggests. The ECHAS app (Emergency...

A Machine Learning Tool for Diagnosing, …

Scientists aiming to advance cancer diagnostics have developed a machine learning tool that is able to identify metabolism-related molecular profile differences between patients with colorectal cancer and healthy people. The analysis...

Fine-Tuned LLMs Boost Error Detection in…

A type of artificial intelligence (AI) called fine-tuned large language models (LLMs) greatly enhances error detection in radiology reports, according to a new study published in Radiology, a journal of...

DeepSeek-R1 Offers Promising Potential t…

A joint research team from The Hong Kong University of Science and Technology and The Hong Kong University of Science and Technology (Guangzhou) has published a perspective article in MedComm...

Deep Learning can Predict Lung Cancer Ri…

A deep learning model was able to predict future lung cancer risk from a single low-dose chest CT scan, according to new research published at the ATS 2025 International Conference...